Cytokine Gene Expression and Treatment Impact on MRI Outcomes in Jordanian Patients with Multiple Sclerosis

Background: Central nervous system autoimmune disorders, like multiple sclerosis (MS), are chronic conditions where cytokines contribute significantly to the regulation of inflammation. The diagnosis, progression, and treatment effectiveness of MS are assessed through laboratory tests and clinical e...

Full description

Saved in:
Bibliographic Details
Main Authors: Sawsan I. Khdair, Mohammed Waleed, Alaa M. Hammad, Lubna Al-Khareisha, Tariq Jaber, Majd Ayash, Frank Scott Hall
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/15/6/859
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849432459099242496
author Sawsan I. Khdair
Mohammed Waleed
Alaa M. Hammad
Lubna Al-Khareisha
Tariq Jaber
Majd Ayash
Frank Scott Hall
author_facet Sawsan I. Khdair
Mohammed Waleed
Alaa M. Hammad
Lubna Al-Khareisha
Tariq Jaber
Majd Ayash
Frank Scott Hall
author_sort Sawsan I. Khdair
collection DOAJ
description Background: Central nervous system autoimmune disorders, like multiple sclerosis (MS), are chronic conditions where cytokines contribute significantly to the regulation of inflammation. The diagnosis, progression, and treatment effectiveness of MS are assessed through laboratory tests and clinical evaluation, as well as imaging. Method: This study included 40 healthy individuals as a control group and 75 MS patients, divided into two groups: 45 MS patients receiving fingolimod treatment (MSW) and 30 patients taking other medications (MSOs). Blood samples (3 mL) were collected from all participants, and the mRNA relative expression of cytokine genes (<i>IL-1β</i>, <i>TNF-α</i>, <i>IL-6</i>, and <i>INF-γ</i>) was measured. Additionally, MRI images of MS patients undergoing fingolimod or other treatments were analyzed. Results: The MSO patient group displayed higher mRNA expressions of <i>IL-1β</i>, <i>TNF-α</i>, <i>IL-6</i>, and <i>INF-γ</i> compared to the control group. Furthermore, <i>TNF-α</i>, <i>IL-6</i>, and <i>INF-γ</i> expressions were elevated in the MSO group compared to the MSW group. MRI scans showed significant improvement in MS patients taking fingolimod compared to those receiving other medications. Conclusions: Fingolimod demonstrated greater effectiveness in improving MS patients’ conditions, possibly due to its impact on cytokine expression.
format Article
id doaj-art-e39db2247be84f28a89691b9a818df37
institution Kabale University
issn 2075-1729
language English
publishDate 2025-05-01
publisher MDPI AG
record_format Article
series Life
spelling doaj-art-e39db2247be84f28a89691b9a818df372025-08-20T03:27:21ZengMDPI AGLife2075-17292025-05-0115685910.3390/life15060859Cytokine Gene Expression and Treatment Impact on MRI Outcomes in Jordanian Patients with Multiple SclerosisSawsan I. Khdair0Mohammed Waleed1Alaa M. Hammad2Lubna Al-Khareisha3Tariq Jaber4Majd Ayash5Frank Scott Hall6Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, JordanFaculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, JordanFaculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman 11733, JordanDepartment of Pharmacy, Al-Bashir Hospital, Ashrafeya, P.O. Box 10005, Amman 11151, JordanDepartment of Neurosurgery, Al-Bashir Hospital, Ashrafeya, P.O. Box 10005, Amman 11151, JordanDepartment of Neurosurgery, Al-Bashir Hospital, Ashrafeya, P.O. Box 10005, Amman 11151, JordanDepartment of Pharmacology and Experimental Therapeutics, University of Toledo, Toledo, OH 43606, USABackground: Central nervous system autoimmune disorders, like multiple sclerosis (MS), are chronic conditions where cytokines contribute significantly to the regulation of inflammation. The diagnosis, progression, and treatment effectiveness of MS are assessed through laboratory tests and clinical evaluation, as well as imaging. Method: This study included 40 healthy individuals as a control group and 75 MS patients, divided into two groups: 45 MS patients receiving fingolimod treatment (MSW) and 30 patients taking other medications (MSOs). Blood samples (3 mL) were collected from all participants, and the mRNA relative expression of cytokine genes (<i>IL-1β</i>, <i>TNF-α</i>, <i>IL-6</i>, and <i>INF-γ</i>) was measured. Additionally, MRI images of MS patients undergoing fingolimod or other treatments were analyzed. Results: The MSO patient group displayed higher mRNA expressions of <i>IL-1β</i>, <i>TNF-α</i>, <i>IL-6</i>, and <i>INF-γ</i> compared to the control group. Furthermore, <i>TNF-α</i>, <i>IL-6</i>, and <i>INF-γ</i> expressions were elevated in the MSO group compared to the MSW group. MRI scans showed significant improvement in MS patients taking fingolimod compared to those receiving other medications. Conclusions: Fingolimod demonstrated greater effectiveness in improving MS patients’ conditions, possibly due to its impact on cytokine expression.https://www.mdpi.com/2075-1729/15/6/859cytokinesfingolimodmultiple sclerosisJordaniansMRIrelative gene expression
spellingShingle Sawsan I. Khdair
Mohammed Waleed
Alaa M. Hammad
Lubna Al-Khareisha
Tariq Jaber
Majd Ayash
Frank Scott Hall
Cytokine Gene Expression and Treatment Impact on MRI Outcomes in Jordanian Patients with Multiple Sclerosis
Life
cytokines
fingolimod
multiple sclerosis
Jordanians
MRI
relative gene expression
title Cytokine Gene Expression and Treatment Impact on MRI Outcomes in Jordanian Patients with Multiple Sclerosis
title_full Cytokine Gene Expression and Treatment Impact on MRI Outcomes in Jordanian Patients with Multiple Sclerosis
title_fullStr Cytokine Gene Expression and Treatment Impact on MRI Outcomes in Jordanian Patients with Multiple Sclerosis
title_full_unstemmed Cytokine Gene Expression and Treatment Impact on MRI Outcomes in Jordanian Patients with Multiple Sclerosis
title_short Cytokine Gene Expression and Treatment Impact on MRI Outcomes in Jordanian Patients with Multiple Sclerosis
title_sort cytokine gene expression and treatment impact on mri outcomes in jordanian patients with multiple sclerosis
topic cytokines
fingolimod
multiple sclerosis
Jordanians
MRI
relative gene expression
url https://www.mdpi.com/2075-1729/15/6/859
work_keys_str_mv AT sawsanikhdair cytokinegeneexpressionandtreatmentimpactonmrioutcomesinjordanianpatientswithmultiplesclerosis
AT mohammedwaleed cytokinegeneexpressionandtreatmentimpactonmrioutcomesinjordanianpatientswithmultiplesclerosis
AT alaamhammad cytokinegeneexpressionandtreatmentimpactonmrioutcomesinjordanianpatientswithmultiplesclerosis
AT lubnaalkhareisha cytokinegeneexpressionandtreatmentimpactonmrioutcomesinjordanianpatientswithmultiplesclerosis
AT tariqjaber cytokinegeneexpressionandtreatmentimpactonmrioutcomesinjordanianpatientswithmultiplesclerosis
AT majdayash cytokinegeneexpressionandtreatmentimpactonmrioutcomesinjordanianpatientswithmultiplesclerosis
AT frankscotthall cytokinegeneexpressionandtreatmentimpactonmrioutcomesinjordanianpatientswithmultiplesclerosis